INTRODUCTION: Radiofrequency catheter ablation (RFCA) is an effective therapy for atrial fibrillation (AF). This study was designed to investigate the effects of RFCA on left ventricular (LV) structure and function in AF patients. METHODS AND RESULTS: A systematic literature search in MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials was performed to identify trials involving changes of LV structure and function in AF patients undergoing RFCA. Effect size was expressed as weighted mean difference (WMD) with 95% confidence interval (CI). LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and LV ejection fraction (LVEF) were estimated. A total of 21 trials including 1,135 participants were qualified for this meta-analysis. Compared to the baseline values, there were significant decreases in LVEDV (WMD, -6.39 ml; 95%CI, -12.46 to -0.33) and LVESV (WMD, -6.39 ml; 95%CI, -11.35 to -1.42) and a significant improvement in LVEF (WMD, 6.23%; 95%CI, 3.70 to 8.75), but no significant changes were observed in LVEDD (WMD, -0.64 mm; 95%CI, -2.40 to 1.13) and LVESD (WMD, -0.38 mm; 95%CI, -1.32 to 0.56) after RFCA. Subgroup analysis demonstrated that patients with low LVEF (WMD, 11.90%; 95%CI, 9.16 to 14.64) gained more benefits than those with normal LVEF (WMD, 1.56%; 95%CI, 0.38 to 2.74). Besides, patients with chronic AF (WMD, 10.96%; 95%CI, 4.92 to 17.01) improved more than those with paroxysmal AF (WMD, 1.93%; 95%CI, -0.27 to 4.12). CONCLUSIONS: RFCA in AF patients could reverse LV structural remodeling and improve LV systolic function, especially in patients with low LVEF and chronic AF.
INTRODUCTION: Radiofrequency catheter ablation (RFCA) is an effective therapy for atrial fibrillation (AF). This study was designed to investigate the effects of RFCA on left ventricular (LV) structure and function in AFpatients. METHODS AND RESULTS: A systematic literature search in MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials was performed to identify trials involving changes of LV structure and function in AFpatients undergoing RFCA. Effect size was expressed as weighted mean difference (WMD) with 95% confidence interval (CI). LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and LV ejection fraction (LVEF) were estimated. A total of 21 trials including 1,135 participants were qualified for this meta-analysis. Compared to the baseline values, there were significant decreases in LVEDV (WMD, -6.39 ml; 95%CI, -12.46 to -0.33) and LVESV (WMD, -6.39 ml; 95%CI, -11.35 to -1.42) and a significant improvement in LVEF (WMD, 6.23%; 95%CI, 3.70 to 8.75), but no significant changes were observed in LVEDD (WMD, -0.64 mm; 95%CI, -2.40 to 1.13) and LVESD (WMD, -0.38 mm; 95%CI, -1.32 to 0.56) after RFCA. Subgroup analysis demonstrated that patients with low LVEF (WMD, 11.90%; 95%CI, 9.16 to 14.64) gained more benefits than those with normal LVEF (WMD, 1.56%; 95%CI, 0.38 to 2.74). Besides, patients with chronic AF (WMD, 10.96%; 95%CI, 4.92 to 17.01) improved more than those with paroxysmal AF (WMD, 1.93%; 95%CI, -0.27 to 4.12). CONCLUSIONS: RFCA in AFpatients could reverse LV structural remodeling and improve LV systolic function, especially in patients with low LVEF and chronic AF.
Authors: Yong-Mei Cha; Anita Wokhlu; Samuel J Asirvatham; Win-Kuang Shen; Paul A Friedman; Thomas M Munger; Jae K Oh; Kristi H Monahan; Janis M Haroldson; David O Hodge; Regina M Herges; Stephen C Hammill; Douglas L Packer Journal: Circ Arrhythm Electrophysiol Date: 2011-07-11
Authors: U Ravens; K Davia; C H Davies; P O'Gara; A J Drake-Holland; J W Hynd; M I Noble; S E Harding Journal: Cardiovasc Res Date: 1996-09 Impact factor: 10.787
Authors: Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia Journal: Pacing Clin Electrophysiol Date: 2006-09 Impact factor: 1.976
Authors: Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski Journal: J Cardiovasc Electrophysiol Date: 2006-11-01
Authors: Boris A Lutomsky; Thomas Rostock; Andreas Koops; Daniel Steven; Kai Müllerleile; Helge Servatius; Imke Drewitz; Denis Ueberschär; Thorsten Plagemann; Rodolfo Ventura; Thomas Meinertz; Stephan Willems Journal: Europace Date: 2008-04-01 Impact factor: 5.214
Authors: Laurens F Tops; Dennis W Den Uijl; Victoria Delgado; Nina Ajmone Marsan; Katja Zeppenfeld; Eduard Holman; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Circ Arrhythm Electrophysiol Date: 2009-04-17
Authors: Rohan S Wijesurendra; Alexander Liu; Christian Eichhorn; Rina Ariga; Eylem Levelt; William T Clarke; Christopher T Rodgers; Theodoros D Karamitsos; Yaver Bashir; Matthew Ginks; Kim Rajappan; Tim Betts; Vanessa M Ferreira; Stefan Neubauer; Barbara Casadei Journal: Circulation Date: 2016-09-14 Impact factor: 29.690